Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2001
01/23/2001US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
01/23/2001US6177283 Detecting components in sample; provide blotter and applying sample liquid, dry liquid on blotter, elute and count preferential component from dried sample
01/23/2001US6177282 Immunoassay for detecting binding agents in sample; incubating sample with phosphatide binding agent, detect preferentially bound phosphatides
01/23/2001US6177281 Device for the efficient and accurate detection and analysis of compounds in a sample
01/23/2001US6177280 Ricin inhibitors and methods for use thereof
01/23/2001US6177277 Cytometric process for analyzing cells and particles in a sample; providing a flow cytometer, activating fluid sample flowing through channel in cuvette and detecting fluorescent signal
01/23/2001US6177276 Oxidation and measurement of phosphonates in aqueous solutions
01/23/2001US6177270 Reaction-based selection for expression of and concentration of catalytic moieties
01/23/2001US6177260 Simple, efficient method of analyzing thiol group containing proteins, glutathione, cysteine, flavonoids, and vitamin e by contacting in active and deactive state with oxidant resulting in change of absorbance spectra and comparing
01/23/2001US6177259 Screening for inhibitors by incubating caspase, polyglutamine peptide, and candidate where reduction in complex formation indicates inhibitor; treatment of nervous system disorders such as huntington's disease
01/23/2001US6177257 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility
01/23/2001US6177255 Immunoassay method by contacting tumor tissue cytosol with antihormone receptor antibody to form complex, removing liquid, incubating complex with hormone or antihormone, contacting with enzyme labeled antibody, measuring color
01/23/2001US6177253 Screening methods for the identification of anti-HIV compounds employing a cyclosporine-specific monoclonal antibody that cross-reacts with HIV-1 p24
01/23/2001US6177251 Separating mammalian nucleic acid from sample by removing particulate matter from sample in a lysis buffer, then separating out nucleic acids; buffer does not lyse bacterial cells; screening for mutation in gene indicative of cancer
01/23/2001US6177250 Nucleic acid mediated electron transfer
01/23/2001US6177248 Detecting expression of at least one gene down-stream from wt1 and comparing to wild type cells; a difference suggests mutation; diagnosis of cancer/tumor
01/23/2001US6177247 Distinguishing different nucleic acid sequences produced using polymerase by incorporating different fluorescent energy transfer labels into each nucleic acid, separating, irradiating with light, and detecting emission; sequencing
01/23/2001US6177245 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
01/23/2001US6177243 Nucleic acid sequence detection employing amplification probes
01/23/2001US6177241 Use of peptides to improve specificity of an immunoassay for the detection of cytomegalovirus specific IgM antibody
01/23/2001US6177106 Method for fractionating red blood cells and antibacterial materials for bacterial proliferation inhibitors produced thereby
01/23/2001US6177088 Surface-functionalized, probe-containing nanospheres
01/23/2001US6177081 Human and marmoset activating viruses
01/23/2001US6177051 Dispenser, analyzer, detector
01/23/2001US6177000 Biosensor operates by detecting or measuring the transport of ions across a lipid membrane
01/23/2001US6176990 Micro-electrophoresis chip for moving and separating nucleic acids and other charged molecules
01/23/2001US6176974 Method for determining electrokinetic properties of papermaking furnish
01/23/2001US6176199 Method for localizing allantoic fluid of avian eggs
01/23/2001US6176120 Methods of analyzing water soluble contaminants generated during microelectronic device manufacturing processes
01/23/2001CA2296884C Targeted liposomes and methods for liposome-protein coupling
01/23/2001CA2221178C Wholly microfabricated biosensors and process for the manufacture and use thereof
01/23/2001CA2219640C Fluid testing and analysing device and method
01/23/2001CA2122473C Nuclear matrix protein fluid assay
01/23/2001CA2017369C Modified phosphoramidite process for the production or modified nucleic acids
01/18/2001WO2001004828A1 Automated detection of objects in a biological sample
01/18/2001WO2001004636A1 Mammalian cells expressing desaturases and elongases
01/18/2001WO2001004635A1 Rapid test employing an adhesive slide
01/18/2001WO2001004634A1 Antigen recovery and/or staining apparatus and method
01/18/2001WO2001004633A2 Preparation of spheres for diagnostic tests
01/18/2001WO2001004632A1 Oligosaccharide metabolites of glycosaminoglycans and their use in the diagnosis and treatment of complications of diabetes
01/18/2001WO2001004631A1 A sensor comprising a hydrophilic matrix material
01/18/2001WO2001004630A1 Measurement of analytes in whole blood
01/18/2001WO2001004629A1 E4orf4 and pp2a polypeptides, modulators, and mimetics for selectively inducing cell death
01/18/2001WO2001004628A1 Method for assaying compounds affecting cell division
01/18/2001WO2001004627A1 Soil measuring instrument, soil measurement assisting device and method, recorded medium on which program is recorded, recorded medium on which data is recorded, application amount controller, application amount determining device, method for them, and farm working determination assisting system
01/18/2001WO2001004626A1 An electrochemical method for enrichment of microorganism, a biosensor for analyzing organic substance and bod
01/18/2001WO2001004623A1 Optical sensor for potassium ions
01/18/2001WO2001004620A1 Improved method and device for counting inclusions in a liquid metal bath with ultrasounds
01/18/2001WO2001004614A1 Electrochemical biosensor using silver silver chloride electrode and chromatography matrix
01/18/2001WO2001004613A1 Microfabricated injector and capillary array assembly for high-resolution and high throughput separations
01/18/2001WO2001004612A2 A method of determining the content of a component in a fluid sample and an apparatus therefor
01/18/2001WO2001004607A1 Image data analysis of objects
01/18/2001WO2001004361A2 Detection of hiv-1 by nucleic acid amplification
01/18/2001WO2001004354A2 Use of ras inhibitors of inhibiting muscle atrophy
01/18/2001WO2001004351A2 Genetic test for detecting a predisposition to a disease associated with abnormal vegf gene expression
01/18/2001WO2001004350A1 Cell line comprising the promoter of cyclooxygenase-2 (cox-2) and a witness gene, and use thereof in the search of cox-2 transcriptional induction selective inhibitors
01/18/2001WO2001004349A2 Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease
01/18/2001WO2001004344A2 Induction of a th1-like response in vitro
01/18/2001WO2001004343A2 A method for determining the prognosis of cancer patients by measuring levels of bag expression
01/18/2001WO2001004326A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same
01/18/2001WO2001004318A2 Myxoma virus genes for immune modulation
01/18/2001WO2001004316A2 Antigenic meningococcal peptides
01/18/2001WO2001004311A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/18/2001WO2001004309A1 T-CELL RECEPTOR η ALTERNATE READING FRAME PROTEIN, (TARP) AND USES THEREOF
01/18/2001WO2001004308A1 Human lim domain proteins
01/18/2001WO2001004306A1 Expression vectors and methods
01/18/2001WO2001004305A2 Human proteins involved in detoxification
01/18/2001WO2001004304A1 Human cytokine receptor
01/18/2001WO2001004303A1 Compositions corresponding to a calcium transporter and methods of making and using same
01/18/2001WO2001004298A1 Novel physiologically active substance, process for producing the same and use thereof
01/18/2001WO2001004292A1 G-protein coupled receptor and dna sequences thereof
01/18/2001WO2001004287A1 A method for preparing modified polypeptides
01/18/2001WO2001004281A2 Dna coding for beta-tubulin and use thereof
01/18/2001WO2001004265A2 C-terminal protein tagging
01/18/2001WO2001004264A2 Atherosclerosis-associated genes
01/18/2001WO2001004158A1 Method for determining dna double-stranded breaks
01/18/2001WO2001004157A2 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS
01/18/2001WO2001004151A2 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY
01/18/2001WO2001004141A2 Seripancrin
01/18/2001WO2001004133A1 Human eag2
01/18/2001WO2001004057A1 Method and apparatus for removing oil from water including monitoring of adsorbent saturation
01/18/2001WO2001003841A1 System and self-moving device for the control of milling processes
01/18/2001WO2001003743A1 Manipulation of tissue or organ type using the notch pathway
01/18/2001WO2001003722A1 Cftr polypeptides, fragments thereof and methods of use to overcome biosynthetic misprocessing
01/18/2001WO2001003721A1 Improved assays for detecting human immunodeficiency virus infection
01/18/2001WO2001003720A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
01/18/2001WO2001003692A1 Compositions and methods for promoting nerve regeneration
01/18/2001WO2001003582A1 Medical measuring device
01/18/2001WO2001003573A2 Method of diagnosis of cardiac hypertrophy
01/18/2001WO2000063415A8 Dna encoding the human vanilloid receptor vr1
01/18/2001WO2000063378A3 Zalpha13: a human secreted protein
01/18/2001WO2000056864A3 Methods for altering substrate specificity of phosphoinositide-dependent-protein kinase 1 (pdk1)
01/18/2001WO2000055180A3 Human lung cancer associated gene sequences and polypeptides
01/18/2001WO2000049382A3 Bead dispensing system
01/18/2001WO2000047723A3 Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same
01/18/2001WO2000043782A3 Removal of prions from blood, plasma and other liquids
01/18/2001WO2000032825A3 Development of anti-microbial agents based on bacteriophage genomics
01/18/2001WO2000019210A3 Determining the mechanism of beta-amyloid peptide generation
01/18/2001WO1999064620A3 Diagnostic assay requiring a small sample of biological fluid
01/18/2001WO1999064049A9 Novel antibacterial agents